Page 422 - Clinical Hematology_ Theory _ Procedures ( PDFDrive )

406 PART 6 ■ Neoplastic Disorders

■ A AML m j m . D - ■ I ALL, m m m m –
m AML m . T

. k % % ,

■ A m m HLA-m k m × /L.
. L % x m k

P m AML m k - k m × /L. I

m - m , x m x m % k

% % . .

■ N m m AML ■ S m k x m -
ALL. z m z

k , DNA DNA.

m , x , (+) m m

x m , m - m j ALL -

, k m m - . B- , x m B- ALL,

■ A AML - m m
m m CD , AML.

- j - ■ T ALLA m %

( -CD CD ). CD ALL. CD x

. ALL.

■ A m k m
Acute Lymphoblastic Leukemia m k .

■ T m m m ALL
■ I U S , ALL m mm m x m

, % m m

. m .

■ ALL m , k ■ , % . A % %

ALL m ,

. P ALL m % % m x -

. m m . m ALL

■ T ALL m

. T .

H , m W ,

B k .

■ S D ’ m - Life-Threatening Emergencies

k ALL, m

z . ■ T m mm - m -

■ S q q - k m , ,

ALL . k m , m m ,

■ T FAB ALL L ( ), k .

L ( ), L ( - ■ ALL m .

k m B k ’ m m ).

■ ALL m - B- . Future Trends: Vaccines

■ T WHO m FAB

L L B- m - ■ V , AML, -

k m / m m m ( B- ALL) . A ,

- m k m / m m (PR )

m m ( - ALL), . W m m - (W ),

■ P B-ALL m m mm - mm k m m

B- . P -ALL m

m mm - . AML .